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Abstract Deletion analysis of the fl subunit of the human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor previously defined 
two cytoplasmic regions required for distinct signaling. The membrane-proximal region is responsible for induction of c-myc and pim-1, and is 
indispensable for GM-CSF-dependent proliferation of mouse BaF3 transfectants. The distal region is required for activation of Ras, Raf-1, MAP 
kinase and p70 $6 kinase as well as induction ofc-fos and c-jun, but is dispensable for GM-CSF-dependent proliferation oftransfectants under normal 
culture conditions containing serum. Here we show that signals induced by the distal region of the fl subunit are also required for proliferation. 
GM-CSF supported proliferation of BaF3 transfectants expressing the normal fl subunit, even in serum-free medium. However, in the absence of 
serum, GM-CSF did not support proliferation of BaF3 transfectants hat have the fl deletion mutants lacking the distal region. Serum-induced 
activation of Ras, phosphorylation f MAP kinase and expression of c-fos in parental BaF3 ceils and antisense oligonucleotide against c-rafblocked 
DNA synthesis of BaF3 cells. These results indicate that proliferation of BaF3 cells requires ignals induced by the proximal as well as the distal 
region of the fl subunit of the GM-CSF receptor, and that serum alleviates the requirement of signals induced by the distal region. 
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1. Introduction 
The high affinity receptors for granulocyte-macrophage col- 
ony-stimulating factor (GM-CSF), interleukin-3 (IL-3) and in- 
terleukin-5 (IL-5) consist of two distinct subunits, ~ and fl [1]. 
The ~ subunits are specific for each cytokine and bind their 
specific ligand with low affinity. The three receptors hare the 
common fl subunit (tic) that does not bind any cytokine by itself 
but forms a high affinity receptor for the GM-CSF, IL-3 and 
IL-5 with the respective ~ subunit. The tic subunit is not only 
required for high affinity binding of a ligand, but is also essen- 
tial for signal transduction. Although none of these subunits 
has intrinsic kinase activity, binding of these cytokines to their 
receptors induces rapid tyrosine phosphorylation including the 
tic subunit itself [2-7]. Several tyrosine kinases, Lyn, Fyn, Fes, 
and Jak2 have been implicated in the GM-CSF/IL-3 signaling 
pathway [8-11]. Presumably, activation of one or some of these 
tyrosine kinases leads to activation of p21 ras (Ras), and serine/ 
threonine kinases, Raf-1 and MAP kinase as well as induc- 
tion of nuclear protooncogenes such as c-myc, c-fos and c-jun 
[12-19]. 
BaF3 is an IL-3-dependent cell line originally described as a 
pro-B cell line [20] and has been widely used to study the 
function of cytokine receptors [21-25]. A series of cytoplasmic 
deletion mutants of the human tic subunit has been coexpressed 
with the human GM-CSF receptor ~t subunit in BaF3 cells and 
their functions in transfectants have been examined [7,26]. Two 
cytoplasmic regions of the fie subunit were found to be impor- 
tant for induction of distinct signals [26]. The membrane-prox- 
imal region of about 60 amino acid residues is responsible for 
induction of c-myc and pim-1 (referred to as the Myc pathway) 
and is indispensable for proliferation. The membrane-distal 
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region is required for GM-CSF-induced activation of Ras, Raf- 
1, MAP kinase and p70 $6 kinase (referred to as the Ras 
pathway). Like the GM-CSF receptor, the deletions of the 
interleukin-2 (IL-2) receptor fl subunit defined two domains in 
the cytoplasmic region responsible for different signaling 
[27,28], i.e. the membrane-proximal serine-rich region is re- 
sponsible for induction of c-myc and indispensable for prolifer- 
ation of BaF3 transfectants, whereas the distal acidic region is 
required for activation of Ras and induction of c-fos and c-jun. 
The acidic region is also responsible for binding Lck, but this 
region is dispensable for proliferation. 
While it is well established that the Ras pathway plays an 
important role for proliferation, these results suggest hat the 
Ras pathway activated by the distal region of the tic subunit is 
dispensable for proliferation of BaF3 cells. However, it should 
be noted that proliferation of BaF3 transfectants expressing the 
GM-CSF receptor or the IL-2 receptor was examined in me- 
dium containing serum [7,21]. We therefore have examined the 
possibility that serum supports growth of transfectants bearing 
the mutant receptor by activating cellular signaling molecules. 
Signals mediated through the distal region of the tic subunit 
were required for GM-CSF-dependent proliferation when 
transfectants were cultured in the absence of serum. Consistent 
with this observation, anti-sense oligonucleotide against c-raf 
inhibited proliferation of BaF3 cells. These results indicate that 
proliferation of BaF3 cells requires the Ras pathway in addition 
to the Myc pathway that are activated through the GM-CSF 
receptor. 
2. Materials and methods 
2.1. Cell lines 
A parental IL-3-dependent mouse pro-B cell line, BaF3 [20] and 
BaF3 transfectants (BaF/~flc, BaF/ctf1763, BaF/0~fl~4, BaF/0tfls~7, and 
BaF/ctf1455 ) expressing the normal or mutant GM-CSF receptor [7] were 
maintained in RPMI 1640 medium (IL-3 medium) supplemented with 
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10% fetal bovine serum (FBS) in the presence of 100 U/ml of mouse 
IL-3 (mlL-3). 
2.2. Cell culture in serum-free medium 
Serum-free medium was prepared according to Cormier et al. [29]. 
BaF3 transfectants cultured in medium containing mlL-3 with 10% 
FBS were washed with serum-free medium twice, and then incubated 
at 1 × 105 cells/ml in serum-free medium containing mlL-3 (100 U/ml) 
or human GM-CSF (1 ng/ml) without or with 10% FBS. 
2.3. Analysis of Ras-bound GDP and GTP 
Activation of Ras was assayed as described previously [12]. In brief, 
0.5-1.0× 107 cells were collected and washed with phosphate-free 
RPMI. Cells were resuspended and incubated in phosphate-free RPMI 
containing 0.1% bovine serum albumin (BSA) (Fraction V, Sigma), 
50/zM Na3VO4 and [32p]orthophosphate (1.0 mCi/ml, DuPont-New 
England Nuclear) for 2.5 h. FBS was added to the cells at final 10%. 
After incubation with FBS for 0-30 min, cells were harvested and lysed 
in modified RIPA buffer. Ras protein was recovered by immunoprecip- 
itation with anti-Ras monoclonal ntibody, YI 3-259. Ras-bound nucle- 
otides were separated by thin-layer chromatography and the radioactiv- 
ity of GDP and GTP was measured. 
2.4. Immunoblot and Northern blot analysis 
BaF3 cells were factor- and serum-deprived for2.5 h, stimulated with 
FBS for 10 min, and lysed in Laemmli's ample buffer. Total cellular 
proteins were separated on SDS-polyacrylamide gels and transferred to 
an immobilon PVDF membrane filter (Millipore). After blocking with 
PBS containing 3% BSA, the membrane was incubated with the pri- 
mary rabbit antibody against p44 MAP kinase (anti-ERK1) (UBI). 
Anti-rabbit Ig (Amersham) coupled with horseradish peroxidase and 
ECL (Amersham) were used to detect protein-primary antibody com- 
plex as described previously [26]. 
For Northern blot analysis, similarly, BaF3 cells were factor- and 
serum-deprived for 8 h and stimulated with FBS or mlL3 for 15 min. 
Total cellular RNA from BaF3 cells was prepared as previously de- 
scribed [26]. Ten micrograms of total RNA from each sample was 
electrophoresed on a 1% agarose-formaldehyde gel and transferred to 
the Nytran filter (S&S). cDNA probes for c-fos and glyceraldehyde 
3-phosphate dehydrogenase (G3PDH) (Clontech) were labeled with 
[ot32p]dCTP and hybridized with the membrane as described previously 
[30]. 
2.5. [3H]Thymidine and BrdU incorporation and cell viabifity assay 
Antisense (5'-TCCCTGTATGTGCTCCAT-3') and sense (5'-ATG- 
GAGCACATACAGGGA-Y) oligonucleotides corresponding tomur- 
ine c-rafwere prepared as described by Carroll et al. [31]. BaF3 cells 
(l × 104) were incubated with fresh IL-3 medium in the absence or 
presence of oligonucleotides. After 24 h, 1/.tCi of [3H]thymidine (3H- 
TdR) (NEN) was added. Incorporation of 3H-TdR into DNA was 
measured after 4 h by liquid scintillation counter. At the same time, cell 
viability was measured by the calorimetric assay after incubation with 
alarmaBlue (Biosource) for 4 h following a 24 h incubation. 
Similarly, after a 24 h incubation, 0.5-1 x 107 cells were also labeled 
with 5-bromo-2-deoxyuridine (BrdU) for 30 min. After fixation with 
70% ethanol and denaturation of the DNA with HC 1, cells were incu- 
bated with FITC-conjugated anti-BrdU antibody (Becton) and then 
analyzed by flow-cytometry with EPICS ELITE (Coulter). 
3. Results 
3.1. Proliferation of  BaF3 transfectants in serum-free medium 
Previously we have shown that BaF3 transfectants expres- 
sing both ~ and tic subunits of  the human GM-CSF  receptor 
proliferate in response to human GM-CSF  (hGM-CSF) [32]. 
A series of cytoplasmic deletion mutants of the tic subunit was 
constructed and their functions were examined in BaF3 cells 
[7,26]. Interestingly, the fl517 as well as fl544 deletions that do not 
induce activation of the Ras pathway were still capable of 
stimulating proliferation. To understand whether the activated 
Ras pathway is dispensable for cell proliferation, we examined 
proliferation assay of BaF3 transfectants in the serum-free me- 
dium. Serum in culture medium might substitute the require- 
ment of the Ras pathway induced by hGM-CSF. As shown in 
Fig. 1, all BaF3 transfectants proliferated continuously in re- 
sponse to mIL-3 even in the absence of serum. In contrast, 
response of these transfectants to hGM-CSF  was different 
under the serum-free condition. BaF/~zflc and BaF/~f1763, which 
activate the Ras pathway in response to hGM-CSF, prolifer- 
ated in the presence of hGM-CSF. However, BaF/~fls,~ and 
BaF/cxf1517 did not proliferate even in the presence of hGM- 
CSF, although their viability was maintained by hGM-CSF  for 
a few days. The addition of serum stimulated proliferation 
of BaF/0~flsa4 and BaF/0~flsl7 in the presence of hGM-CSF. 
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Fig. 1. Cell growth in serum-free medium. Transfectants cultured in medium containing serum were washed with serum-free medium, and then 
incubated in serum-free medium containing mlL-3 (100 U/ml) (open circle), or hGM-CSF (1 ng/ml) without (closed circle), or with 10% FBS (closed 
square). Cell growth of transfectants was monitored by counting viable cell number. 
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BaF/ctf1455, which lacks the entire cytoplasmic domain of tic and 
was unable to induce any signals, did not proliferate ven in the 
presence of both hGM-CSF  and serum. These results indicate 
that serum supports the growth of BaF/ctf1544 and BaF/ctf1517 
which are unable to activate the Ras pathway, and also suggest 
that signals induced by the distal region of  the fl subunit are 
involved in proliferation of BaF3 transfectants. 
3.2. Activation of the Ras pathway by serum 
Despite the fact that hGM-CSF  failed to activate the Ras 
pathway in BaF/~fls,~ and BaF/t~flSl7, both transfectants prolif- 
erated in response to hGM-CSF  in the presence of serum. We 
therefore xamined the possibility that serum induces activa- 
tion of the Ras pathway in BaF3 cells. BaF3 cells deprived of 
serum and mlL-3 were stimulated with serum, and the accumu- 
lation of  GTP-bound Ras (Ras. GTP) was measured (Fig. 2A). 
Serum increased Ras .GTP  approximately 1.5-fold compared 
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Fig. 3. Effect of c-raf antisense oligonucleotide. (A) BaF3 cells were 
incubated for 24 h in fresh medium containing mlL-3 and 10% FBS 
without or with antisense (1 and 0.1 pM) or sense (1 and 0.1 pM) 
oligonucleotides against c-raf. For cell viability assay or mitogenic 
assay, cells were incubated for an additional 4h alamarBlue (open bar) 
or 3H-TdR (solid bar), respectively, as described in section 2. (B) BaF3 
cells incubated without or with antisense (1 pM) and sense (1/~M) for 
24 h were labeled with BrdU for 30 min, stained with FITC-conjugated 
anti-BrdU antibody, and analyzed by flow-cytometry as described in 
section 2. 
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Fig. 2. Activation of molecules on the Ras pathway by serum. (A) Ras 
activation in BaF3 cells. BaF3 cells were incubated in phosphate-free 
RPMI medium with [32p]orthophosphate for 2.5 h, stimulated with FBS 
for 0-30 min at final 10%, and then lysed. Ras protein was immunopre- 
cipitated with anti-Ras antibody, Y13-259 and the radioactivity of 
GDP and GTP bound to Ras proteins was analyzed as described in 
section 2. (B) Mobility shift of MAP kinase, mlL-3- and serum-de- 
prived BaF3 cells were incubated without (lane 1) and with 10% FBS 
(lane 2) or 10 ng/ml mlL-3 (lane 3) for 10 min. Total cellular proteins 
(1.2 x 105 cells/lane) were separated by SDS-10% PAGE and p44 MAP 
kinase (ERKI) was identified by immunoblotting using anti-ERKl 
antibody. (C) Induction of c-fos in BaF3 cells, mlL-3- and serum- 
deprived BaF3 cells were stimulated with FBS (lane 2) or 10 ng/ml 
mlL-3 (lane 3) for 15 min. Total RNA was electrophoresed on formal- 
dehyde-l% agarose gel and transferred onto a nylon membrane. The 
same membrane was used for hybridization with the radiolabeled c-fos 
and G3PDH, respectively. 
with the unstimulated cells. The increase was smaller compared 
to the stimulation with mlL-3 (5- to 10-fold), but is significant. 
To further confirm that serum induces activation of  the Ras 
pathway, we examined the phosphorylation of MAP kinase, 
downstream of Ras. As shown in Fig. 2B, serum as well as 
mlL-3 clearly induced a mobility shift of MAP kinase, which 
is known to result from phosphorylation [17]. Similarly, serum 
induced expression of the c-fos mRNA as well (Fig. 2C). These 
results clearly indicate that serum leads to activation of the Ras 
pathway in BaF3 cells. 
3.3. Inhibition of proliferation by the antisense c-raf 
oligonucleo tide 
To investigate the role of the Ras pathway, we focused on 
Raf-1, which is a downstream olecule of  Ras and activates 
MAP kinase [33,34], and examined the effect of antisense oli- 
gonucleotide against c-raf to BaF3 cells. Antisense or sense 
oligonucleotide against c-rafwas added to culture medium con- 
taining mlL-3. After 24 h, cell viability and mitogenic activity 
of BaF3 cells were measured by alamarBlue and thymidine 
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uptake (Fig. 3A). Although these oligonucleotides did not af- 
fect cell viability of BaF3 cells, DNA synthesis was significantly 
inhibited by addition of antisense, but not sense, oligonucleo- 
tides. We also observed that DNA synthesis of BaF/ctflc stimu- 
lated by hGM-CSF is inhibited by addition of antisense 
oligonucleotide (data not shown). Labeling of DNA by BrdU 
is also decreased by addition of antisense oligonucleotide (Fig. 
3B). Further, Myc protein level measured by immunoblotting 
was not significantly changed by the treatment with antisense- 
or sense-oligonucleotide against c-raf(data not shown). These 
results indicate that the function of c-raf is required for prolif- 
eration of BaF3 cells and also suggest that signals on the Ras 
pathway are important for regulating the Gl to S phase transi- 
tion in hematopoietic cells. 
4. Discussion 
Previously we demonstrated that there are at least two dis- 
tinct regions in the cytoplasmic domain of the tic subunit of the 
GM-CSF receptor: the membrane-proximal region is respon- 
sible for induction of c-myc and pim-1 (the Myc pathway) and 
the distal region is required for activation of Ras, Raf-1, MAP 
kinase and p70 $6 kinase and for expression of c-fos and c-jun 
(the Ras pathway) [26]. Whereas the membrane-proximal re- 
gion is indispensable for proliferation, the distal region is dis- 
pensable for GM-CSF-dependent growth in medium contain- 
ing serum [7]. Here we demonstrate hat serum is required for 
proliferation of transfectants expressing the truncated GM- 
CSF receptor which is unable to activate any molecules in the 
Ras pathway. 
Recent studies suggest hat Ras, Raf-1, MAP kinase, and 
c-foslc-jun form a signaling pathway referred to as the Ras 
pathway in this paper [33,34], i.e. activated-Ras ctivates Raf-I 
which activates MAP kinase through MAP kinase kinase. This 
pathway appears to be common among various growth factors, 
cytokines and serum, and plays an important role in survival, 
proliferation and differentiation of cells. The previous report 
suggested that the Ras pathway is dispensable for proliferation 
of hematopoietic cells [28]. However, our results provide two 
lines of evidence that the Ras pathway plays an important role 
in proliferation of hematopoietic cells driven by IL-3/GM-CSF. 
First, BaF/ctf1544 or BaF/otflsl7 lacking the ability to activate the 
Ras pathway in response to hGM-CSF did not proliferate in 
serum-free condition (Fig. 1). Second, antisense oli- 
gonucleotide against c-raf blocked proliferation of BaF3 cells 
(Fig. 3) and BaF/~flc (data not shown). We have further demon- 
strated that serum alleviates the requirement of GM-CSF-in- 
duced activation of the Ras pathway (Fig. 2). However, it 
should be noted that serum may activate the Ras pathway not 
only through Ras, but also other signaling molecules which 
may directly activate Raf-1, MAP kinase kinase, or MAP ki- 
nase. At present it is not known what component of serum 
activates the Ras pathway in BaF3 cells and BaF3 transfec- 
tants. 
While Raf-1 is required for proliferation of BaF3 cells (Fig. 
3) and IL-3-dependent FDC-P1 cells [31], the activated Raf-1 
did not abrogate the IL-3 requirement ofFDC-P 1 and 32D cells 
[35]. We have also confirmed that v-raf did not abrogate the 
IL-3 requirement of BaF3 cells (data not shown). Thus the Ras 
pathway is necessary, but not sufficient for proliferation of 
hematopoietic cell lines. Expression of c-myc is induced by 
hGM-CSF in BaF/0~fls,~ and BaF/0tfls~7 , but hGM-CSF did not 
stimulate proliferation of these cells in serum-free condition, 
indicating that the signals induced by the membrane proximal 
region of tic (the Myc pathway) is also not sufficient for prolif- 
eration. Shibuya et al. demonstrated that constitutive xpres- 
sion of c-myc was not sufficient for proliferation of BaF3 ceils 
[36]. In combination with v-raf, v-myc was able to induce fac- 
tor-independent growth of myeloid cell lines [35]. Thus, like 
fibroblasts, the Ras pathway and the Myc pathway coopera- 
tively stimulate cell proliferation of hematopoietic cells. 
In the previous paper we described that BaF/ctflsl7 proceeded 
the G~ to S phase transition in response to hGM-CSF even in 
the absence of serum [26]. However, the transition was signifi- 
cantly slower compared to BaF/0~flc. Furthermore, these cells 
did not proliferate in the absence of serum (Fig. 1). Although 
Myc has been implicated in DNA synthesis, controversial re- 
suits were also reported. Shibuya et al. suggested that Myc 
plays a role in S to GJM transition in BaF3 cells [36]. TGFfll 
is known to arrest cell cycle at G1 phase in several cell lines by 
regulating cyclin-dependent kinases [37], and interestingly, this 
G~ arrest by TGFfll is counteracted by microinjection of onco- 
genic Ras [38]. Thus, it is possible that the Ras pathway plays 
an important role in regulation of the transition from G~ to S 
phase. To understand the role of the Ras pathway in cytokine- 
mediated cell proliferation it is necessary to identify the ulti- 
mate targets through this pathway. 
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